ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacokinetic Research Service Market Research Report 2026
Published Date: 2026-03-04
|
Report Code: QYRE-Auto-10M17826
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacokinetic Research Service Market Research Report 2024
BUY CHAPTERS

Global Pharmacokinetic Research Service Market Research Report 2026

Code: QYRE-Auto-10M17826
Report
2026-03-04
Pages:140
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PPD
Charles River
BioPharma Services
QPS Holdings
ALTASCIENCES
Allucent
Admescope Ltd
CTI
WuXi AppTec
GenScript
Wuxi Biologics
Medicilon
Pharmaron
Frontage
Shanghai Model

Pharmacokinetic Research Service Market

The global Pharmacokinetic Research Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Pharmacokinetic Research Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Pharmacokinetic Research Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Pharmacokinetic Research Service in Pharmaceutical Industry is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Pharmacokinetic Research Service include Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences, Allucent, Admescope, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Pharmacokinetic Research Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmacokinetic Research Service. The Pharmacokinetic Research Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmacokinetic Research Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmacokinetic Research Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Pharmacokinetic Research Service Market Report

Report Metric Details
Report Name Pharmacokinetic Research Service Market
Segment by Type
  • In Vitro and Radioactive ADME
  • In Vivo PK and PD
  • New Drugs and New Molecules
  • Other
Segment by Application
  • Pharmaceutical Industry
  • Government and Ministry of Health
  • Agriculture and Chemical Industry
  • University
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences, Allucent, Admescope, CTI, WuXi AppTec, GenScript, Wuxi Biologics, Medicilon, Pharmaron, Frontage, Shanghai Model
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Pharmacokinetic Research Service companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacokinetic Research Service Market report?

Ans: The main players in the Pharmacokinetic Research Service Market are Eurofins, PPD, LabCorp, Charles River, BioPharma Services, Biotrial, QPS Holdings, Altasciences, Allucent, Admescope, CTI, WuXi AppTec, GenScript, Wuxi Biologics, Medicilon, Pharmaron, Frontage, Shanghai Model

What are the Application segmentation covered in the Pharmacokinetic Research Service Market report?

Ans: The Applications covered in the Pharmacokinetic Research Service Market report are Pharmaceutical Industry, Government and Ministry of Health, Agriculture and Chemical Industry, University

What are the Type segmentation covered in the Pharmacokinetic Research Service Market report?

Ans: The Types covered in the Pharmacokinetic Research Service Market report are In Vitro and Radioactive ADME, In Vivo PK and PD, New Drugs and New Molecules, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetic Research Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vitro and Radioactive ADME
1.2.3 In Vivo PK and PD
1.2.4 New Drugs and New Molecules
1.2.5 Other
1.3 Market by Application
1.3.1 Global Pharmacokinetic Research Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Government and Ministry of Health
1.3.4 Agriculture and Chemical Industry
1.3.5 University
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetic Research Service Market Perspective (2021–2032)
2.2 Global Pharmacokinetic Research Service Growth Trends by Region
2.2.1 Global Pharmacokinetic Research Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharmacokinetic Research Service Historic Market Size by Region (2021–2026)
2.2.3 Pharmacokinetic Research Service Forecasted Market Size by Region (2027–2032)
2.3 Pharmacokinetic Research Service Market Dynamics
2.3.1 Pharmacokinetic Research Service Industry Trends
2.3.2 Pharmacokinetic Research Service Market Drivers
2.3.3 Pharmacokinetic Research Service Market Challenges
2.3.4 Pharmacokinetic Research Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetic Research Service Players by Revenue
3.1.1 Global Top Pharmacokinetic Research Service Players by Revenue (2021–2026)
3.1.2 Global Pharmacokinetic Research Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharmacokinetic Research Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharmacokinetic Research Service Revenue
3.4 Global Pharmacokinetic Research Service Market Concentration Ratio
3.4.1 Global Pharmacokinetic Research Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetic Research Service Revenue in 2025
3.5 Global Key Players of Pharmacokinetic Research Service Head Offices and Areas Served
3.6 Global Key Players of Pharmacokinetic Research Service, Products and Applications
3.7 Global Key Players of Pharmacokinetic Research Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharmacokinetic Research Service Breakdown Data by Type
4.1 Global Pharmacokinetic Research Service Historic Market Size by Type (2021–2026)
4.2 Global Pharmacokinetic Research Service Forecasted Market Size by Type (2027–2032)
5 Pharmacokinetic Research Service Breakdown Data by Application
5.1 Global Pharmacokinetic Research Service Historic Market Size by Application (2021–2026)
5.2 Global Pharmacokinetic Research Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharmacokinetic Research Service Market Size (2021–2032)
6.2 North America Pharmacokinetic Research Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharmacokinetic Research Service Market Size by Country (2021–2026)
6.4 North America Pharmacokinetic Research Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetic Research Service Market Size (2021–2032)
7.2 Europe Pharmacokinetic Research Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharmacokinetic Research Service Market Size by Country (2021–2026)
7.4 Europe Pharmacokinetic Research Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetic Research Service Market Size (2021–2032)
8.2 Asia-Pacific Pharmacokinetic Research Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharmacokinetic Research Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharmacokinetic Research Service Market Size (2021–2032)
9.2 Latin America Pharmacokinetic Research Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharmacokinetic Research Service Market Size by Country (2021–2026)
9.4 Latin America Pharmacokinetic Research Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetic Research Service Market Size (2021–2032)
10.2 Middle East & Africa Pharmacokinetic Research Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharmacokinetic Research Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Details
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Pharmacokinetic Research Service Introduction
11.1.4 Eurofins Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.1.5 Eurofins Recent Development
11.2 PPD
11.2.1 PPD Company Details
11.2.2 PPD Business Overview
11.2.3 PPD Pharmacokinetic Research Service Introduction
11.2.4 PPD Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.2.5 PPD Recent Development
11.3 LabCorp
11.3.1 LabCorp Company Details
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Pharmacokinetic Research Service Introduction
11.3.4 LabCorp Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.3.5 LabCorp Recent Development
11.4 Charles River
11.4.1 Charles River Company Details
11.4.2 Charles River Business Overview
11.4.3 Charles River Pharmacokinetic Research Service Introduction
11.4.4 Charles River Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.4.5 Charles River Recent Development
11.5 BioPharma Services
11.5.1 BioPharma Services Company Details
11.5.2 BioPharma Services Business Overview
11.5.3 BioPharma Services Pharmacokinetic Research Service Introduction
11.5.4 BioPharma Services Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.5.5 BioPharma Services Recent Development
11.6 Biotrial
11.6.1 Biotrial Company Details
11.6.2 Biotrial Business Overview
11.6.3 Biotrial Pharmacokinetic Research Service Introduction
11.6.4 Biotrial Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.6.5 Biotrial Recent Development
11.7 QPS Holdings
11.7.1 QPS Holdings Company Details
11.7.2 QPS Holdings Business Overview
11.7.3 QPS Holdings Pharmacokinetic Research Service Introduction
11.7.4 QPS Holdings Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.7.5 QPS Holdings Recent Development
11.8 Altasciences
11.8.1 Altasciences Company Details
11.8.2 Altasciences Business Overview
11.8.3 Altasciences Pharmacokinetic Research Service Introduction
11.8.4 Altasciences Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.8.5 Altasciences Recent Development
11.9 Allucent
11.9.1 Allucent Company Details
11.9.2 Allucent Business Overview
11.9.3 Allucent Pharmacokinetic Research Service Introduction
11.9.4 Allucent Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.9.5 Allucent Recent Development
11.10 Admescope
11.10.1 Admescope Company Details
11.10.2 Admescope Business Overview
11.10.3 Admescope Pharmacokinetic Research Service Introduction
11.10.4 Admescope Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.10.5 Admescope Recent Development
11.11 CTI
11.11.1 CTI Company Details
11.11.2 CTI Business Overview
11.11.3 CTI Pharmacokinetic Research Service Introduction
11.11.4 CTI Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.11.5 CTI Recent Development
11.12 WuXi AppTec
11.12.1 WuXi AppTec Company Details
11.12.2 WuXi AppTec Business Overview
11.12.3 WuXi AppTec Pharmacokinetic Research Service Introduction
11.12.4 WuXi AppTec Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.12.5 WuXi AppTec Recent Development
11.13 GenScript
11.13.1 GenScript Company Details
11.13.2 GenScript Business Overview
11.13.3 GenScript Pharmacokinetic Research Service Introduction
11.13.4 GenScript Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.13.5 GenScript Recent Development
11.14 Wuxi Biologics
11.14.1 Wuxi Biologics Company Details
11.14.2 Wuxi Biologics Business Overview
11.14.3 Wuxi Biologics Pharmacokinetic Research Service Introduction
11.14.4 Wuxi Biologics Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.14.5 Wuxi Biologics Recent Development
11.15 Medicilon
11.15.1 Medicilon Company Details
11.15.2 Medicilon Business Overview
11.15.3 Medicilon Pharmacokinetic Research Service Introduction
11.15.4 Medicilon Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.15.5 Medicilon Recent Development
11.16 Pharmaron
11.16.1 Pharmaron Company Details
11.16.2 Pharmaron Business Overview
11.16.3 Pharmaron Pharmacokinetic Research Service Introduction
11.16.4 Pharmaron Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.16.5 Pharmaron Recent Development
11.17 Frontage
11.17.1 Frontage Company Details
11.17.2 Frontage Business Overview
11.17.3 Frontage Pharmacokinetic Research Service Introduction
11.17.4 Frontage Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.17.5 Frontage Recent Development
11.18 Shanghai Model
11.18.1 Shanghai Model Company Details
11.18.2 Shanghai Model Business Overview
11.18.3 Shanghai Model Pharmacokinetic Research Service Introduction
11.18.4 Shanghai Model Revenue in Pharmacokinetic Research Service Business (2021–2026)
11.18.5 Shanghai Model Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
PPD
Charles River
BioPharma Services
QPS Holdings
ALTASCIENCES
Allucent
Admescope Ltd
CTI
WuXi AppTec
GenScript
Wuxi Biologics
Medicilon
Pharmaron
Frontage
Shanghai Model
List of Tables
 Table 1. Global Pharmacokinetic Research Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of In Vitro and Radioactive ADME
 Table 3. Key Players of In Vivo PK and PD
 Table 4. Key Players of New Drugs and New Molecules
 Table 5. Key Players of Other
 Table 6. Global Pharmacokinetic Research Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Pharmacokinetic Research Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Pharmacokinetic Research Service Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Pharmacokinetic Research Service Market Share by Region (2021–2026)
 Table 10. Global Pharmacokinetic Research Service Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Pharmacokinetic Research Service Market Share by Region (2027–2032)
 Table 12. Pharmacokinetic Research Service Market Trends
 Table 13. Pharmacokinetic Research Service Market Drivers
 Table 14. Pharmacokinetic Research Service Market Challenges
 Table 15. Pharmacokinetic Research Service Market Restraints
 Table 16. Global Pharmacokinetic Research Service Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Pharmacokinetic Research Service Market Share by Players (2021–2026)
 Table 18. Global Top Pharmacokinetic Research Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharmacokinetic Research Service Revenue, 2025
 Table 19. Ranking of Global Top Pharmacokinetic Research Service Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Pharmacokinetic Research Service Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Pharmacokinetic Research Service, Headquarters and Area Served
 Table 22. Global Key Players of Pharmacokinetic Research Service, Products and Applications
 Table 23. Global Key Players of Pharmacokinetic Research Service, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Pharmacokinetic Research Service Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Pharmacokinetic Research Service Revenue Market Share by Type (2021–2026)
 Table 27. Global Pharmacokinetic Research Service Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Pharmacokinetic Research Service Revenue Market Share by Type (2027–2032)
 Table 29. Global Pharmacokinetic Research Service Market Size by Application (US$ Million), 2021–2026
 Table 30. Global Pharmacokinetic Research Service Revenue Market Share by Application (2021–2026)
 Table 31. Global Pharmacokinetic Research Service Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global Pharmacokinetic Research Service Revenue Market Share by Application (2027–2032)
 Table 33. North America Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Pharmacokinetic Research Service Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Pharmacokinetic Research Service Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Pharmacokinetic Research Service Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Pharmacokinetic Research Service Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Pharmacokinetic Research Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Pharmacokinetic Research Service Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Pharmacokinetic Research Service Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Pharmacokinetic Research Service Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Pharmacokinetic Research Service Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Pharmacokinetic Research Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Pharmacokinetic Research Service Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Pharmacokinetic Research Service Market Size by Country (US$ Million), 2027–2032
 Table 48. Eurofins Company Details
 Table 49. Eurofins Business Overview
 Table 50. Eurofins Pharmacokinetic Research Service Product
 Table 51. Eurofins Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 52. Eurofins Recent Development
 Table 53. PPD Company Details
 Table 54. PPD Business Overview
 Table 55. PPD Pharmacokinetic Research Service Product
 Table 56. PPD Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 57. PPD Recent Development
 Table 58. LabCorp Company Details
 Table 59. LabCorp Business Overview
 Table 60. LabCorp Pharmacokinetic Research Service Product
 Table 61. LabCorp Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 62. LabCorp Recent Development
 Table 63. Charles River Company Details
 Table 64. Charles River Business Overview
 Table 65. Charles River Pharmacokinetic Research Service Product
 Table 66. Charles River Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 67. Charles River Recent Development
 Table 68. BioPharma Services Company Details
 Table 69. BioPharma Services Business Overview
 Table 70. BioPharma Services Pharmacokinetic Research Service Product
 Table 71. BioPharma Services Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 72. BioPharma Services Recent Development
 Table 73. Biotrial Company Details
 Table 74. Biotrial Business Overview
 Table 75. Biotrial Pharmacokinetic Research Service Product
 Table 76. Biotrial Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 77. Biotrial Recent Development
 Table 78. QPS Holdings Company Details
 Table 79. QPS Holdings Business Overview
 Table 80. QPS Holdings Pharmacokinetic Research Service Product
 Table 81. QPS Holdings Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 82. QPS Holdings Recent Development
 Table 83. Altasciences Company Details
 Table 84. Altasciences Business Overview
 Table 85. Altasciences Pharmacokinetic Research Service Product
 Table 86. Altasciences Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 87. Altasciences Recent Development
 Table 88. Allucent Company Details
 Table 89. Allucent Business Overview
 Table 90. Allucent Pharmacokinetic Research Service Product
 Table 91. Allucent Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 92. Allucent Recent Development
 Table 93. Admescope Company Details
 Table 94. Admescope Business Overview
 Table 95. Admescope Pharmacokinetic Research Service Product
 Table 96. Admescope Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 97. Admescope Recent Development
 Table 98. CTI Company Details
 Table 99. CTI Business Overview
 Table 100. CTI Pharmacokinetic Research Service Product
 Table 101. CTI Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 102. CTI Recent Development
 Table 103. WuXi AppTec Company Details
 Table 104. WuXi AppTec Business Overview
 Table 105. WuXi AppTec Pharmacokinetic Research Service Product
 Table 106. WuXi AppTec Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 107. WuXi AppTec Recent Development
 Table 108. GenScript Company Details
 Table 109. GenScript Business Overview
 Table 110. GenScript Pharmacokinetic Research Service Product
 Table 111. GenScript Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 112. GenScript Recent Development
 Table 113. Wuxi Biologics Company Details
 Table 114. Wuxi Biologics Business Overview
 Table 115. Wuxi Biologics Pharmacokinetic Research Service Product
 Table 116. Wuxi Biologics Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 117. Wuxi Biologics Recent Development
 Table 118. Medicilon Company Details
 Table 119. Medicilon Business Overview
 Table 120. Medicilon Pharmacokinetic Research Service Product
 Table 121. Medicilon Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 122. Medicilon Recent Development
 Table 123. Pharmaron Company Details
 Table 124. Pharmaron Business Overview
 Table 125. Pharmaron Pharmacokinetic Research Service Product
 Table 126. Pharmaron Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 127. Pharmaron Recent Development
 Table 128. Frontage Company Details
 Table 129. Frontage Business Overview
 Table 130. Frontage Pharmacokinetic Research Service Product
 Table 131. Frontage Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 132. Frontage Recent Development
 Table 133. Shanghai Model Company Details
 Table 134. Shanghai Model Business Overview
 Table 135. Shanghai Model Pharmacokinetic Research Service Product
 Table 136. Shanghai Model Revenue in Pharmacokinetic Research Service Business (US$ Million), 2021–2026
 Table 137. Shanghai Model Recent Development
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Pharmacokinetic Research Service Picture
 Figure 2. Global Pharmacokinetic Research Service Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Pharmacokinetic Research Service Market Share by Type: 2025 vs 2032
 Figure 4. In Vitro and Radioactive ADME Features
 Figure 5. In Vivo PK and PD Features
 Figure 6. New Drugs and New Molecules Features
 Figure 7. Other Features
 Figure 8. Global Pharmacokinetic Research Service Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global Pharmacokinetic Research Service Market Share by Application: 2025 vs 2032
 Figure 10. Pharmaceutical Industry Case Studies
 Figure 11. Government and Ministry of Health Case Studies
 Figure 12. Agriculture and Chemical Industry Case Studies
 Figure 13. University Case Studies
 Figure 14. Pharmacokinetic Research Service Report Years Considered
 Figure 15. Global Pharmacokinetic Research Service Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 16. Global Pharmacokinetic Research Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Pharmacokinetic Research Service Market Share by Region: 2025 vs 2032
 Figure 18. Global Pharmacokinetic Research Service Market Share by Players in 2025
 Figure 19. Global Pharmacokinetic Research Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 20. The Top 10 and 5 Players Market Share by Pharmacokinetic Research Service Revenue in 2025
 Figure 21. North America Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. North America Pharmacokinetic Research Service Market Share by Country (2021–2032)
 Figure 23. United States Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Canada Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Pharmacokinetic Research Service Market Share by Country (2021–2032)
 Figure 27. Germany Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. France Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. U.K. Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Italy Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Russia Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Ireland Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Pharmacokinetic Research Service Market Share by Region (2021–2032)
 Figure 35. China Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Japan Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. South Korea Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Southeast Asia Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. India Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Australia & New Zealand Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Pharmacokinetic Research Service Market Share by Country (2021–2032)
 Figure 43. Mexico Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Brazil Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Pharmacokinetic Research Service Market Share by Country (2021–2032)
 Figure 47. Israel Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Saudi Arabia Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. UAE Pharmacokinetic Research Service Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. Eurofins Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 51. PPD Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 52. LabCorp Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 53. Charles River Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 54. BioPharma Services Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 55. Biotrial Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 56. QPS Holdings Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 57. Altasciences Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 58. Allucent Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 59. Admescope Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 60. CTI Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 61. WuXi AppTec Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 62. GenScript Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 63. Wuxi Biologics Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 64. Medicilon Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 65. Pharmaron Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 66. Frontage Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 67. Shanghai Model Revenue Growth Rate in Pharmacokinetic Research Service Business (2021–2026)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Pharmacokinetic Research Market Research Report 2024
Global Pharmacokinetic Service Market Research Report 2025
Global Pharmacokinetics Software Market Research Report 2024
Global Pharmacokinetics Testing Service Market Research Report 2024
Global Bioanalytical Research Service Market Research Report 2025
Global Research and Development Service Market Research Report 2024
Drug Discovery and Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Transporter Service Market Research Report 2025
Global IVD Research Service Market Research Report 2025
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Research Support Services Market Research Report 2024
Global Pharmacology Discovery Service Market Research Report 2024
Global Toxicological Services Market Research Report 2024
Global Clinical Trials Support Service Market Research Report 2024
Oncology Drug Discovery Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Market Research Consulting Services Market Research Report 2024
Global Global Mobility Service Market Research Report 2024
Pharmacokinetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Technology Transfer Services Market Research Report 2025
Global API Drug Development Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions